Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen

NCT02739477 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER_GOV

Sponsor class

Stopped End date of epidemic

Conditions

Ebola Virus Survivor

Interventions

DRUG: Favipiravir

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France